CTRI/2017/10/010089
Completed
未知
Safety and efficacy of quick penetrating Heparin solution for prophylaxis against superficial venous cannula- A prospective, randomized, comparative clinical study.
PARUL INSTITUTE OF MEDICAL SCIENCE AND RESEARCH0 sites100 target enrollmentTBD
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Health Condition 1: O- Medical and Surgical
- Sponsor
- PARUL INSTITUTE OF MEDICAL SCIENCE AND RESEARCH
- Enrollment
- 100
- Status
- Completed
- Last Updated
- 4 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Planned to undergo peripheral vein cannulation that has been planned to remain in situ for at least 48 hours of indoor period
Exclusion Criteria
- •1\.Undergoing re\-cannulation due to phlebitis at earlier cannulation site 2\.Unconscious or comatose patients
- •3\.History of hypersensitivity reaction to heparin or heparin induced thrombocytopenia
- •4\. Signs of systemic infection, bacteremia
- •5\. Planned administration of any of the following during study period:
- •5\.1 Anti\-coagulants locally (in the cannula) or systemically.
- •5\.2 NSAIDs locally over surrounding area
- •6\. Participated in any clinical trial within last 30 days at the time of screening.
- •7\. Any disorder or condition that in the opinion of investigator would prohibit study participation or affect study outcome.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
Examination of usefulness and safety of heparinoid agent based external medicine (over counter drug) for facial dryness symptom.JPRN-UMIN000018986Osaka city university graduate school of medicine, department of dermatology50
Completed
Phase 2
Heparin administration in coronary angiographyAtherosclerotic heart disease.Atherosclerotic heart diseaseIRCT201202199080N1Hamadan university of medical sciences500
Completed
Phase 1
Evaluation of the Effect of Subcutaneous Heparin Injection on Pain Intensity and Bruising IncidenceTreatment: protocol designed to evaluate one or more interventions for treating a disease,syndrome or conditionHeparin SodiumTCTR20160221001Mashhad university of medical sciences86
Not yet recruiting
Phase 2
The Evaluation of effectiveness of heparin nebulizer in reduction of respiratory distress in patients with COVID-19COVID-19.COVID-19, virus identifiedU07.1IRCT20210513051275N1Islamic Azad University60
Completed
Not Applicable
Effectiveness of low-molecular-weight heparin for prevention of deep venous thrombosis after surgery for colorectal cancer in Japanese patients: a randomized controlled phase III trialJPRN-UMIN000030582Tokyo Metropolitan Hiroo Hospital160